BLUE BELL, Pa.--(BUSINESS WIRE)--Inovio Pharmaceuticals, Inc. (NYSE Amex: INO), a leader in the development of preventive and therapeutic vaccines against cancers and infectious diseases, announced today that president and CEO, Dr. J. Joseph Kim will present a corporate update on its DNA vaccines for influenza, HIV and cancer and its vaccine delivery technology at the following investor conferences:
